You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
The most transformative drugs of the past 25 years: a survey of physicians
|
|---|---|
| Published in |
Nature Reviews Drug Discovery, May 2013
|
| DOI | 10.1038/nrd3977 |
| Pubmed ID | |
| Authors |
Aaron S. Kesselheim, Jerry Avorn |
| Abstract |
Strategic and legislative efforts to catalyse pharmaceutical innovation may be hampered by a lack of consensus over what characterizes an innovative drug. To help clarify this issue, we conducted an extensive survey on transformative drug development, involving ∼180 expert physicians based at 30 leading US academic medical centres, covering 15 medical specialties. In an iterative Delphi process, the survey participants narrowed a list of all new drugs approved in their fields in the past 25 years and reached consensus over those that they considered to be most transformative, which are presented in this article. Participants were also asked how various factors affected their opinion; they most often invoked the effectiveness and superiority of the drugs over existing alternatives when identifying transformative drug innovation. |
X Demographics
The data shown below were collected from the profiles of 40 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | 20% |
| United Kingdom | 6 | 15% |
| Germany | 3 | 8% |
| Canada | 2 | 5% |
| Spain | 1 | 3% |
| France | 1 | 3% |
| Mexico | 1 | 3% |
| Austria | 1 | 3% |
| Japan | 1 | 3% |
| Other | 3 | 8% |
| Unknown | 13 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 22 | 55% |
| Scientists | 14 | 35% |
| Practitioners (doctors, other healthcare professionals) | 3 | 8% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 3% |
| United Kingdom | 3 | 2% |
| Colombia | 1 | <1% |
| Germany | 1 | <1% |
| Sri Lanka | 1 | <1% |
| Portugal | 1 | <1% |
| Greece | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 114 | 90% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 39 | 31% |
| Other | 20 | 16% |
| Student > Ph. D. Student | 13 | 10% |
| Professor | 12 | 9% |
| Student > Bachelor | 10 | 8% |
| Other | 27 | 21% |
| Unknown | 6 | 5% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 34 | 27% |
| Medicine and Dentistry | 28 | 22% |
| Chemistry | 19 | 15% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 7% |
| Biochemistry, Genetics and Molecular Biology | 8 | 6% |
| Other | 19 | 15% |
| Unknown | 10 | 8% |
Attention Score in Context
This research output has an Altmetric Attention Score of 69. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 March 2023.
All research outputs
#617,224
of 25,468,708 outputs
Outputs from Nature Reviews Drug Discovery
#277
of 3,667 outputs
Outputs of similar age
#4,371
of 208,942 outputs
Outputs of similar age from Nature Reviews Drug Discovery
#3
of 47 outputs
Altmetric has tracked 25,468,708 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,667 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.1. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 208,942 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.